A Controlled Trial of Extended-Release Guanfacine and Psychostimulants for Attention-Deficit/Hyperactivity Disorder

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

Ronald C. Kessler, Patricia A. Berglund, Olga Demler et al. · Archives of General Psychiatry · 2005 · 20.1K citations

ECDEU Assessment Manual for Psychopharmacology

William Guy · Bulletin of Miscellaneous Information (Royal Gardens Kew) · 1976 · 8.8K citations

Psychiatric Evaluation, Psychiatry, Ecdeu Assessment Manual +6

Lifetime Prevalence of Mental Disorders in U.S. Adolescents: Results from the National Comorbidity Survey Replication–Adolescent Supplement (NCS-A)

Kathleen R. Merikangas, Jianping He, Marcy Burstein et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2010 · 6.2K citations · Full text

Lifetime Prevalence, Teen Mental Health, Mental Disorders +9

Clinical Relevance of the Primary Findings of the MTA: Success Rates Based on Severity of ADHD and ODD Symptoms at the End of Treatment

James M. Swanson, Helena C. Kraemer, Stephen P. Hinshaw et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2001 · 1.1K citations

Adhd, Psychiatry, Medicine +13

A Placebo-Controlled Study of Guanfacine in the Treatment of Children With Tic Disorders and Attention Deficit Hyperactivity Disorder

Phillip Chappell, Y S Kim, Robert T. Schultz et al. · American Journal of Psychiatry · 2001 · 581 citations